Prevention of Pulmonary Embolism in high risk trauma patients

Slides:



Advertisements
Similar presentations
Hollie Shaner-McRae DNP RN FAAN
Advertisements

LHD Logo Venous Thromboembolism Reducing the Risk DATE.
Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.
The changing role of IVC filters DR R Uberoi John Radcliffe Hospital Oxford.
Chapter Six Venous Disease Coalition Acute Management of VTE VTE Toolkit.
VTE in abdominal-pelvic surgery patients
+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.
Joint Hospital Surgical Grand Round
Prophylaxis of Venous Thromboembolism
Venous thromboembolism –
Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.
Deep Vein Thrombosis (DVT)
Ch 17. Systemic complications DEEP VENOUS THROMBOSIS.
VTE Prophylaxis Alert to providers and nursing Go live June 24, 2014.
Complications Of Vena Cava Filters Amr Fares MD,FRCS Assistant prof. of surgery,Weill cornell college of medicine Vascular surgery consultant Doha –Qatar.
Venous thromboembolism: how long to treat?
DVT/VTE Nursing Protocol (Deep Vein Thrombosis) (Venous Thromboembolism) Presented by Maribeth Desiongco MA, RN-BC 2008.
Chapter Two Venous Disease Coalition Pathogenesis and Consequences of VTE VTE Toolkit.
LIFEBLOOD THE Thrombosis CHARITY Venous thromboembolism – Treatment and secondary prevention Ulcus cruris Chronic PE PE DVT Post-thrombotic syndrome Death.
Unprovoked DVT in a young patient
Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.
Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.
PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM
Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,
Semuloparin for Thromboprophylaxis in Patients Receiving Chemotherapy for Cancer Agnelli G et al. N Engl J Med 2012;366(7): George D et al. Proc.
Cancer-Associated Thrombosis
Spotlight Case May 2003 Central Line Complications in an Infant webmm.ahrq.gov.
DEFINING THE DURATION OF ANTICOAGULATION. HOW LONG TO TREAT A DVT?
ANTICOAGULATION THERAPY OR CATHETER DIRECTED THROMBOLYSIS Alice Marinho, Carlos Veterano, Maricruz Nunes, Patrícia Baptista, Pedro Aguiar, Pedro Campelo,
Oral Rivaroxaban for Symptomatic Venous Thrombroenbolism Group /06/11.
Preoperative Management of Hypoxic Patients
Pulmonary Embolism Treatment in Cancer - Is It Different 34th Brazilian Thoracic Conference 6th ALAT Congress 5th Brazil-Portugal Congress Brazilia/DF.
HICKMAN CATHETER Thrombotic complications associated with venous access devic Thrombotic complications associated with venous access devices Occlusion.
LIFEBLOOD THE Thrombosis CHARITY LIFEBLOOD THE Thrombosis CHARITY NICE Clinical Guideline 46.
Deep vein thrombosis Pulmonary embolism Deep vein thrombosis Pulmonary embolism Venous Thromboembolism TreatmentTreatment …All the same?
IVC filters what you need to know Sam Chakraverty Consultant Radiologist Ninewells Hospital Dundee, Scotland.
DVT & PE: How early can I mobilize a patient ??
Risk Assessment for VTE. Which of the following best describes you?
Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism 1 (RECORD 1 ) Journal Club General Surgery Rotation.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.
Applying CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) in a Pre- Hospital Wilderness Context Paul B. Jones PGY1.
DEEP VEIN THROMBOSIS (DVT) BY CJ HEYKOOP AND KAYTLYN JORDAN.
Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.
Venous Thromboembolism (VTE) Prophylaxis at Cesarean Section Phillip N. Rauk, MD.
Venous Thromboembolism (VTE) Etiology, Prevention, Recognition, and Treatment 1.
Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.
Antithrombotic and Thrombolytic Therapy for Valvular Disease Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy and Prevention.
Role of Physical Therapists in the Management of Individuals at Risk for or Diagnosed With Venous Thromboembolism: Evidence-Based Clinical Practice Guideline.
DEEP VEIN THROMBOSIS BLOCK 2 Lecture Professor Nora Martin Vetto.
Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe.
Conclusions Results Methods Background Venous thrombo-embolism in patients undergoing neo- adjuvant chemotherapy and surgery for oesophago-gastric cancer.
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients Copyright: American College of Chest Physicians 2012 © Antithrombotic Therapy.
Spotlight Case January 2006 An Ounce of Prevention.
Outpatient DVT assessment & treatment Daniel Gilada.
Review on NOACs Studies DR. KOUROSH SADEGHI TEHRAN UNIVERSITY OF MEDICAL SCIENCES.
BLOCK 2 Lecture Professor Nora Martin Vetto
Clinical case Case Presentation: IVC Retrievable and Permanent Filters
By: Dr. Nalaka Gunawansa
The efficacy and safety of oral Rivaroxaban in patients with permanent inferior vena cava filter: a pilot case-control study Lobastov K., Barinov V.,
CRT 2012 Venous Disease.
Jaideep Patel, Stephanie Detterline, M.D., Robert Ferguson, M.D.
Outpatient Venous Thromboembolism Prophylaxis in Lower Limb Injuries:
Prevention of Venous Thromboembolism in Orthopedic Surgery Patients
Optional IVC Filters: Indications for Placement and Retrieval
Timothy A. Brighton, M. B. , B. S. , John W. Eikelboom, M. B. , B. S
HICKMAN CATHETER. HICKMAN CATHETER Thrombotic complications associated with venous access devices Occlusion of lumen Fibrin sheath formation Venous.
Clinical Presentations of VTEa,b NOACs VTE Acute Treatment Trials.
Owen N. Johnson, MD, David L
Roger A. Orsini, M.D., Bruce E. Jarrell, M.D. 
Presentation transcript:

Prevention of Pulmonary Embolism in high risk trauma patients Inferior vena cava filters, pharmaceuticals, vasocompressive devices Sean Beard, Jimmy Crick, Ashton Curry, Erica Essex

PICO QUESTION P: Trauma patients at high risk for PE I: Use of inferior vena cava filter C: Prophylactic pharmaceuticals and vasocompressive devices O: Incidence of PE In trauma patients who are at high risk for developing a pulmonary embolism (PE), is the use of an inferior vena cava filter (IVCF) better than the standard care of prophylactic pharmaceuticals and vasocompressive devices for the prevention of a PE?

OBJECTIVES Background Indications vs. Contraindications Effectiveness PE background & incidence IVC filters (IVCF) Why trauma patients? Indications vs. Contraindications Effectiveness Conclusions Clinical Relevance Risks associated with IVCF http://www.uwmedicine.org/Patient-Care/eHealth-Articles/PublishingImages/Inferior-Vena-Cava-Filter.jpg

BACKGROUND PE IVCF Blood clot in lungs Originates in lower extremity Fragments and travels to lungs via the inferior vena cava IVCF Metal alloy device Inserted in the inferior vena cava Traps blood clots Prevents pulmonary emboli (Young, 2010) http://www.youtube.com/watch?v=o-_wL3XWZ1I&app=desktop

IVCF PLACEMENT http://www.youtube.com/watch?v=UvtHCMBm0SA&app=desktop http://www.mbcgraphics.com/images/img_port_ivcfilter.jpg http://www.youtube.com/watch?v=UvtHCMBm0SA&app=desktop

GROSS ANATOMY LAB Thanks to Dr. Hanks and table 2.1

IMPORTANCE PE’s are common (Rajasekhar, 2011) PE’s are deadly PE’s are preventable (Stefanidis, 2006) http://medicalcenter.osu.edu/patientcare/healthcare_services/lung_diseases/lung/embolism/Pages/index.aspx PE is 3rd most common cause of in hospital death in trauma patients surviving the first 24h (Rajasekhar, 2011) Venous thrombolytic event (VTE) is a leading cause of morbidity and mortality in trauma patients PE: most common preventable cause of death in surgical patients (Stefanidis, 2006)

PATIENT PROFILE Types of high risk patients Factors increasing venous thrombotic event (VTE) risk SCI TBI Fractures Pelvic, acetabulum, tibia-fibula, femoral shaft, foot/ankle (Carlin, 2002) History of venous thrombotic event Prolonged immobility Pelvic trauma Age Vascular injury Obesity Blood transfusions (Helling, 2009)

STANDARD OF CARE Prophylactic low dose subcutaneous heparin (LDH) and sequential compression devices (SCD) Effectively reduces the incidence of DVT or PE to <10% 35% of trauma patients are unable to have SCD 14% of high risk trauma patients unable to have LDH (Sekharan, 2001) (Khansarinia, 1995)

CONTRAINDICATIONS TO STANDARD OF CARE Low dose heparin (LDH) TBI SCI Major pelvic and/or acetabulum fractures Spleen or liver injury Gastrointestinal bleeding Hematuria Stroke Traumatic aortic rupture Sequential compression devices (SCD) LE orthopedic fractures Casting (Carlin, 2002)

INDICATIONS FOR USE OF IVCF Patients with known VTE Anticoagulants contraindicated Recurrent PE despite anticoagulant therapy Hx of complication related to anticoagulant therapy (Young, 2010) (Rajasekhar, 2011) Inserted within 48 hours of injury (Carlin, 2002)

EFFECTIVENESS IVCF’s are considered safe and reduce incidence of VTE (Kidane, 2012) Compared to matched controls, PE incidence was significantly lower in IVCF group (Rajasekhar, 2011) http://www.uofmmedicalcenter.org/fv/groups/public/documents/images/277293.jpg

EFFECTIVENESS After 5 year follow-up, IVCF placement is safe and durable in young active trauma patients (Sekharan, 2001) In patients with IVCF, compared to no IVCF: 12 days: 22% decrease in incidence of PE 2 years: 50% decrease in incidence of PE (Decousus, 1998)

POTENTIAL COMPLICATIONS WITH IVCF Erosion through vena cava wall Filter migration Filter infection Thrombus formation caudal to IVCF Inferior vena cava occlusion (Stefanidis, 2006) http://www.youtube.com/watch?v=qlaDA_FRA48

CONCLUSION In trauma patients who are at high risk for PE IVCF’s are more effective than standard of care at preventing the incidence of a PE In patients for whom standard of care is contraindicated IVCF placement is safe and recommended

RELEVANCE TO PHYSICAL THERAPY Awareness of IVCF Indicates patient is at high risk for VTE Prolonged IVCF use correlated with increased incidence of DVT Wells criteria Recognition of IVCF complication Awareness  in the acute care setting we will be working with lots of post surgical patients i.e THR, TKR, pelvic fracutes and other high trauma patients and we must recognize these patients are at a high risk for DVT and PE Indicates pt is at high risk for VTE  if you see this in their past medical hx it’s a good indicator that you should be aware of the S/S of a DVT with this patient

REFERENCES Carlin AM, Tyburski JG, Wilson RF, Steffes C. Prophylactic and therapeutic inferior vena cava filters to prevent pulmonary emboli in trauma patients. Arch. Surg. 2002;137(5): 521–5. Decousus H, Leizorovicz A. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N. Engl. J. Med. 1998;338(7):409–415. Helling TS, Kaswan S, Miller SL, Tretter JF. Practice patterns in the use of retrievable inferior vena cava filters in a trauma population: a single-center experience. J. Trauma. 2009;67(6):1293–6. Khansarinia S, Dennis JW, Veldenz HC, Butcher JL, Hartland L. Prophylactic Greenfield filter placement in selected high-risk trauma patients. J. Vasc. Surg. 1995;22(3):231–5. Kidney B, Madani AM, Vogt K, Girotti M, Malthaner R a, Parry NG. The use of prophylactic inferior vena cava filters in trauma patients: a systematic review. Injury, Int. J. Care Injured. 2012;43(5):542–7.

REFERENCES Rajasekhar A, Lottenberg R, Lottenberg L, Liu H, Ang D. Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines. J. Thromb. Thrombolysis. 2011;32(1):40–6. Sekharan J, Dennis JW, Miranda FE, et al. Long-term follow-up of prophylactic greenfield filters in multisystem trauma patients. J. Trauma. 2001;51(6):1087–90. Stefanidis D, Paton BL, Jacobs DG, et al. Extended interval for retrieval of vena cava filters is safe and may maximize protection against pulmonary embolism. Am. J. Surg. 2006;192(6):789–94. Young T, Tang H, Hughes R. Vena caval filters for the prevention of pulmonary embolism. Cochrane Database of Systematic Reviews. 2010; (2):CD006212.